Wong CJ. Involuntary weight loss. Med Clin North Am. 2014;98:625-643.
Alberg AJ, Brock MV, Ford JG, et al. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(suppl 5):S1-S29.
1. Wong CJ. Involuntary weight loss. Med Clin North Am. 2014;98:625-643.
2. Marton KI, Sox HC, Krupp JR. Involuntary weight loss: diagnostic and prognostic significance. Ann Intern Med. 1981;95:568-574.
3. Rabinovitz M, Pitlik SD, Leifer M, et al. Unintentional weight loss: a retrospective analysis of 154 cases. Arch Intern Med. 1986;146:186-187.
4. Thompson MP, Morris LK. Unexplained weight loss in the ambulatory elderly. J Am Geriatr Soc. 1991;39:497-500.
5. Wallace JI, Schwartz RS, LaCroix AZ, et al. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc. 1995;43:329-337.
6. Bilbao-Garay J, Barba R, Losa-Garcia JE, et al. Assessing clinical probability of organic disease in patients with involuntary weight loss: a simple score. Eur J Intern Med. 2002;13:240-245.
7. Chen SP, Peng LN, Lin MH, et al. Evaluating probability of cancer among older people with unexplained, unintentional weight loss. Arch Gerontol Geriatr. 2010;50(suppl 1):S27-S29.
8. Wu JM, Lin MH, Peng LN, et al. Evaluating diagnostic strategy of older patients with unexplained unintentional body weight loss: a hospital-based study. Arch Gerontol Geriatr. 2011;53:51-54.
9. Bosch X, Monclús E, Escoda O, et al. Unintentional weight loss: Clinical characteristics and outcomes in a prospective cohort of 2677 patients. PLoS One. 2017 Apr 7;12(4):e0175125.
10. Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793-799.
11. Cederholm T, Bosaeus I, Barazzoni R, et al. Diagnostic criteria for malnutrition: an ESPEN consensus statement. Clin Nutr. 2015;34:335-340.
12. Gregg EW, Gerzoff RB, Thompson TJ, et al. Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. Ann Intern Med. 2003;138:383-389.
13. Wannamethee SG, Shaper AG, Lennon L. Reasons for intentional weight loss, unintentional weight loss, and mortality in older men. Arch Intern Med. 2005;165:1035-1040.
14. Sahyoun NR, Serdula MK, Galuska DA. The epidemiology of recent involuntary weight loss in the United States population. J Nutr Health Aging. 2004;8:510-517.
15. Wijnhoven HA, van Zon SK, Twisk J, et al. Attribution of causes of weight loss and weight gain to 3-year mortality in older adults: results from the Longitudinal Aging Study Amsterdam. J Gerontol A Biol Sci Med Sci. 2014;69:1236-1243.
16. Moghadamyeghaneh Z, Hanna MH1, Hwang G, et al. Outcome of preoperative weight loss in colorectal surgery. Am J Surg. 2015;210:291-297.
17. Thirunavukarasu P, Sanghera S, Singla S, et al. Pre-operative unintentional weight loss as a risk factor for surgical outcomes after elective surgery in patients with disseminated cancer. Int J Surg. 2015;18:7-13.
18. El-Kareh R, Pazo V, Wright A, et al. Losing weights: failure to recognize and act on weight loss documented in an electronic health record. J Innov Health Inform. 2015;22:316-322.
19. Guyenet SJ, Schwartz MW. Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J Clin Endocrinol Metab. 2012;97:745-755.
20. Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metabolism. 2012;16:153-166.
21. Argiles JM, Busquets S, Felipe A, et al. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol. 2005;37:1084-1104.
22. Tan BH, Fearon KC. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care. 2008;11:400-407.
23. Zhang X, Ma L, Bao H, et al. Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study. BMC Endocr Disord. 2014;14:54.
24. O’Connor JM, Marmissolle F, Bestani C, et al. Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: results from the large database of a multidisciplinary group clinical multicenter study. Mol Clin Oncol. 2014;2:672-684.
25. Gibril F, Schumann M, Pace A, et al. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore). 2004;83:43-83.
26. Clifton WL, Kneitz A, Cohn WE, et al. Weight loss caused by visceral artery disease. Tex Heart Inst J. 2013;40:320-322.
27. Hansen KJ, Wilson DB, Craven TE, et al. Mesenteric artery disease in the elderly. J Vasc Surg. 2004;40:45-52.
28. Ziegelstein RC. Depression in patients recovering from a myocardial infarction. JAMA. 2001;286:1621-1627.
29. Hackett ML, Anderson CS, House A, et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008;(4):CD003437.
30. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160-174.
31. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050-1053.
32. Rossignol P, Masson S, Barlera S, et al. Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail. 2015;17:424-433.
33. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry. 2003;54:376-387.
34. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J. 2008;31:492-501.
35. Pencharz PB, Durie PR. Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin Nutr. 2000;19:387-394.
36. Milla CE. Nutrition and lung disease in cystic fibrosis. Clin Chest Med. 2007;28:319-330.
37. Mak RH, Cheung W. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens. 2007;16:27-31.
38. Boelaert K, Torlinska B, Holder RL, et al. Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. J Clin Endocrinol Metab. 2010;95:2715-2726.
39. Ross IL, Levitt NS. Addison's disease symptoms - a cross sectional study in urban South Africa. PLoS One. 2013;8:e53526.
41. Fauci AS, Wolff SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore). 1973;52:535-561.
42. Wallace JM, Hannah JB. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study. Chest. 1988;93:926-932.
43. Modilevsky T, Sattler FR, Barnes PF. Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med. 1989;149:2201-2205.
44. Hira SK, Dupont HL, Lanjewar DN, et al. Severe weight loss: the predominant clinical presentation of tuberculosis in patients with HIV infection in India. Natl Med J India. 1998;11:256-258.
45. Gonzalez Saldana N, Macias Parra M, Hernandez Porras M, et al. Pulmonary tuberculous: symptoms, diagnosis and treatment. 19-year experience in a third level pediatric hospital. BMC Infect Dis. 2014;14:401.
46. Miller LG, Asch SM, Yu El, et al. A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin Infect Dis. 2000;30:293-299.
47. Khan A, Sterling TR, Reves R, et al. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med. 2006;174:344-348.
48. Prince DS, Peterson DD, Steiner RM, et al. Infection with mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989;321:863-868.
49. Petri WA. Recent advances in amebiasis. Crit Rev Clin Lab Sci. 1996;33:1-37.
50. Tobón AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg. 2005;73:576-582.
51. Lim J, Ko YH, Joe SH. Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1918-1921.
52. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142:532-546.
53. Pérez-Hernández O, González-Pérez JM, Martínez-Riera A, et al. Involuntary weight loss secondary to metformin use in elderly adults. J Am Geriatr Soc. 2016;64:899-900.
54. Soysal P, Isik AT, Stubbs B, et al. Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2016 Jun 3 [Epub ahead of print].
55. Garcia L, Qi L, Rasor M, et al. The relationship of violence and traumatic stress to changes in weight and waist circumference: longitudinal analyses from the study of women's health across the nation. J Interpers Violence. 2014;29:1459-1476.
56. Almario CV, Chey WD, Iriana S, et al. Computer versus physician identification of gastrointestinal alarm features. Int J Med Inform. 2015;84:1111-1117.
57. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
58. Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317-325.
59. Alberg AJ, Brock MV, Ford JG, et al. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(suppl 5):S1-S29.
60. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers - a different disease. Nat Rev Cancer. 2007;7:778-790.
61. Subramanian J, Govindan R. Lung cancer in never smokers: a review. Clin Oncol. 2007;25:561-570.
62. Wilson DB, Mostafavi K, Craven TE, et al. Clinical course of mesenteric artery stenosis in elderly Americans. Arch Intern Med. 2006;166:2095-2100.
63. Assi HA, Khoury KE, Dbouk H, et al. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis. 2013;5(suppl 1):S2-S8.
64. Abu-Freha N, Lior Y, Shoher S, Novack V, Fich A, Rosenthal A, Etzion O. The yield of endoscopic investigation for unintentional weight loss. Eur J Gastroenterol Hepatol. 2017 May;29(5):602-607.
65. Hernandez JL, Riancho JA, Matorras P, et al. Clinical evaluation for cancer in patients with involuntary weight loss without specific symptoms. Am J Med. 2003;114:631-637.
66. Hernandez JL, Matorras P, Riancho JA, et al. Involuntary weight loss without specific symptoms: a clinical prediction score for malignant neoplasm. Q J Med. 2003;96:649-655.
67. Baicus C, Ionescu R, Tanasescu C. Does this patient have cancer? The assessment of age, anemia, and erythrocyte sedimentation rate in cancer as a cause of weight loss. A retrospective study based on a secondary care university hospital in Romania. Eur J Intern Med. 2006;17:28-31.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台